IP Library Granted Patent US 9,459,249
Granted Patent B2
US 9,459,249 · App. 12/383,832 · Granted Oct 4, 2016

Protein labeling with cyanobenzothiazole conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,459,249
App. No.
12/383,832
Granted
Oct 4, 2016
Kind
B2
Abstract

The invention provides compounds and methods for site-specifically labeling proteins with cyanobenzothiazole derivatives of formula I. For example, the invention provides methods for labeling the N-terminus of a protein that terminates with a cysteine residue. The invention also provides methods for isolating an N-terminally labeled protein and methods for detecting an N-terminally labeled protein.

Claims (12)

1. A compound of formula I:

wherein

Z is H, F, Cl, Br, I, CN, amino, alkylamino, dialkylamino, alkyl ester, carboxy, carboxylic acid salt, alkyl amide, phosphate, alkyl phosphonate, sulfate, alkyl sulfonate, nitro, or (C 1 -C 10 )alkyl optionally unsaturated and optionally substituted with amino, hydroxy, oxo (═O), nitro, thiol, or halo;

each R 1 is independently H, F, Cl, Br, I, CN, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, or (C 1 -C 6 )alkylthio, wherein each alkyl, alkoxy, or alkylthio is optionally substituted with F, Cl, Br, I, amino, alkenyl, alkynyl, cycloalkyl, aryl, alkyl sulfonate, or CO 2 M wherein M is H, an organic cation, or an inorganic cation;

n is 0, 1, or 2;

Y is a linking group comprising (C 1 -C 16 )alkyl optionally substituted with one or more halo, oxo (═O), (C 1 -C 6 )alkyl, or (C 1 -C 6 )alkoxy, and optionally interrupted with one or more N(R 1 ), O, S, or —N—C(═O)— groups; or Y is optionally absent when X is N 3 ; and

X is a fluorescent dye, biotin, HisTag, chitin, a solid support, N 3 , H, or OH, provided that when X is H or OH, the compound of formula I comprises a radioactive moiety or an isotopic variant of any atom other than the carbon or nitrogen atom of the 2-nitrile moiety.

2. The compound of claim 1 wherein Z is H, F, nitro, or alkyl sulfonate, and R 1 is H or F.

3. The compound of claim 2 wherein Y is —(C 1 -C 6 )alkyl-, —O—(C 1 -C 6 )alkyl-, —O—(C 1 -C 6 )alkyl-O—, —O—(C 1 -C 6 )alkyl-NH—, —O—(C 1 -C 6 )alkyl-(CO)NH—, —NH—(C 1 -C 6 )alkyl-NH—, —NH—(CO)(C 1 -C 6 )alkyl-NH—, —NH—(CO)(C 1 -C 6 )alkyl-(CO)—NH—, or —O—(C 1 -C 6 )alkyl-(CO)NH—(C 1 -C 6 )alkyl-.

4. The compound of claim 3 wherein X is N 3 , a fluorescent dye, biotin, HisTag, chitin, or a solid support.

5. The compound of claim 4 , wherein X is N 3 ,

6. The compound of claim 1 wherein the compound of formula I is:

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2009
From: ANDERSON, JESSICA; MEISENHEIMER, PONCHO; SHULTZ, JOHN
To: PROMEGA CORPORATION
Reel/Frame 022851/0541 →